Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Hormone replacement therapy and risk of venous thromboembolism: population based case-control study.

Pérez Gutthann S, García Rodríguez LA, Castellsague J, Duque Oliart A.

BMJ. 1997 Mar 15;314(7083):796-800.

2.

Hormone replacement therapy and the risk of hospitalization for venous thromboembolism: a population-based study in southern Europe.

Varas-Lorenzo C, García-Rodríguez LA, Cattaruzzi C, Troncon MG, Agostinis L, Perez-Gutthann S.

Am J Epidemiol. 1998 Feb 15;147(4):387-90.

PMID:
9508106
3.

Assessment of the risk for venous thromboembolism among users of hormone replacement therapy.

Oger E, Scarabin PY.

Drugs Aging. 1999 Jan;14(1):55-61. Review.

PMID:
10069408
4.

Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER Study.

Canonico M, Oger E, Conard J, Meyer G, Lévesque H, Trillot N, Barrellier MT, Wahl D, Emmerich J, Scarabin PY; EStrogen and THromboEmbolism Risk (ESTHER) Study Group..

J Thromb Haemost. 2006 Jun;4(6):1259-65.

5.

Hormone replacement therapy and the risk of venous thromboembolism: a population-based study.

Renoux C, Dell'Aniello S, Suissa S.

J Thromb Haemost. 2010 May;8(5):979-86. doi: 10.1111/j.1538-7836.2010.03839.x.

6.

Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis.

Canonico M, Plu-Bureau G, Lowe GD, Scarabin PY.

BMJ. 2008 May 31;336(7655):1227-31. doi: 10.1136/bmj.39555.441944.BE. Review.

7.

Case-control study of oral contraceptives and risk of thromboembolic stroke: results from International Study on Oral Contraceptives and Health of Young Women.

Heinemann LA, Lewis MA, Thorogood M, Spitzer WO, Guggenmoos-Holzmann I, Bruppacher R.

BMJ. 1997 Dec 6;315(7121):1502-4.

8.

Postmenopausal estrogen replacement and risk for venous thromboembolism: a systematic review and meta-analysis for the U.S. Preventive Services Task Force.

Miller J, Chan BK, Nelson HD.

Ann Intern Med. 2002 May 7;136(9):680-90. Review. Erratum in: Ann Intern Med. 2003 Feb 18;138(4):360..

PMID:
11992304
9.

Hormone replacement therapy with estradiol and risk of venous thromboembolism--a population-based case-control study.

Høibraaten E, Abdelnoor M, Sandset PM.

Thromb Haemost. 1999 Oct;82(4):1218-21.

PMID:
10544901
10.

Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study.

Renoux C, Dell'aniello S, Garbe E, Suissa S.

BMJ. 2010 Jun 3;340:c2519. doi: 10.1136/bmj.c2519.

11.

Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapy.

Laliberté F, Dea K, Duh MS, Kahler KH, Rolli M, Lefebvre P.

Menopause. 2011 Oct;18(10):1052-9. doi: 10.1097/gme.0b013e3182175e5c.

PMID:
21775912
12.

A reevaluation of the risk for venous thromboembolism with the use of oral contraceptives and hormone replacement therapy.

Douketis JD, Ginsberg JS, Holbrook A, Crowther M, Duku EK, Burrows RF.

Arch Intern Med. 1997 Jul 28;157(14):1522-30. Review.

PMID:
9236553
13.

Venous thromboembolism and oral contraceptive use: a methodological study of diagnostic suspicion and referral bias.

Heinemann LA, Garbe E, Farmer R, Lewis MA.

Eur J Contracept Reprod Health Care. 2000 Sep;5(3):183-91.

PMID:
11131783
14.
15.

Antidepressant drug use and risk of venous thromboembolism.

Jick SS, Li L.

Pharmacotherapy. 2008 Feb;28(2):144-50. doi: 10.1592/phco.28.2.144.

PMID:
18225961
16.

Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study.

Heit JA, Kobbervig CE, James AH, Petterson TM, Bailey KR, Melton LJ 3rd.

Ann Intern Med. 2005 Nov 15;143(10):697-706.

PMID:
16287790
17.

[Oral contraception and menopausal hormone replacement: effects on hemostasis and risk of venous thromboembolism].

Bounameaux H, de Moerloose P, Campana A.

Schweiz Med Wochenschr. 1996 Oct 12;126(41):1756-63. French.

PMID:
8966508
18.

Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study.

Canonico M, Oger E, Plu-Bureau G, Conard J, Meyer G, Lévesque H, Trillot N, Barrellier MT, Wahl D, Emmerich J, Scarabin PY; Estrogen and Thromboembolism Risk (ESTHER) Study Group..

Circulation. 2007 Feb 20;115(7):840-5.

20.

Venous thromboembolism in relation to oral contraceptive use.

Helmrich SP, Rosenberg L, Kaufman DW, Strom B, Shapiro S.

Obstet Gynecol. 1987 Jan;69(1):91-5.

PMID:
3796927
Items per page

Supplemental Content

Support Center